NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

Preparations continue for Government and pharma talks despite Covid-19

By Mindo - 24th Apr 2020

The Covid-19 pandemic has not yet led to a delay in the upcoming talks on a new framework agreement for medicines between the State and the pharmaceutical industry, this newspaper has been told.

“The four-year Framework Agreement on the Supply and Pricing of Medicines was signed in July 2016 between the Department of Health, the HSE, and the Irish Pharmaceutical Healthcare Association (IPHA) and is not due to expire until 31 July,” a Department spokesperson told the Medical Independent (MI) on Wednesday 15 April.

When asked whether the Covid-19 pandemic risked delaying the talks, the spokesperson said “preparations are underway for the commencement of negotiations on a new framework agreement with industry.”

A spokesperson for the IPHA told MI that “there is no date yet on the planned commencement of negotiations”.

The framework negotiations will not include discussion regarding any future Covid-19 vaccine as the Department spokesperson noted that “in accordance with the definitions included in Clause 1, subsection 2 of the Framework Agreement, the definition of ‘medicines’  for the purposes of the agreement specifically excludes blood products, vaccines, and non-reimbursable non-prescription products”.

Separately a spokesperson for the Department told MI that the Irish Government  “is strongly supportive of equitable access to medicines, vaccines and diagnostics, including in relation to Covid-19.”

“The EU and its member states including Ireland are pursuing innovative approaches to combating the Covid-19 pandemic, including coordinated research and development effort, through the WHO and in partnership with other WHO member states and international organisations.”

Leave a Reply

Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read